SH2 containing protein tyrosine phosphatase-2 (SHP2) is a promising candidate for a multifunctional therapeutic target as it is a druggable oncogenic phosphatase expressed in both tumor cells and immune cells (12–14). Here, PTPN11 is linked to neoplasm.